As of 2025-11-17, the Relative Valuation of N4 Pharma PLC (N4P.L) is (1.36) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 0.63 GBP, the upside of N4 Pharma PLC based on Relative Valuation is -317.1%.
The range of the Relative Valuation is (1.23) - (1.46) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 11.4x | 9.5x |
| Forward P/E multiples | 9.6x - 13.1x | 11.7x |
| Fair Price | (1.23) - (1.46) | (1.36) |
| Upside | -297.0% - -333.9% | -317.1% |
| Date | P/E |
| 2025-11-14 | -5.39 |
| 2025-11-13 | -4.92 |
| 2025-11-12 | -5.00 |
| 2025-11-11 | -5.08 |
| 2025-11-10 | -5.16 |
| 2025-11-07 | -5.39 |
| 2025-11-06 | -4.92 |
| 2025-11-05 | -4.80 |
| 2025-11-04 | -4.88 |
| 2025-11-03 | -4.96 |
| 2025-10-31 | -5.19 |
| 2025-10-30 | -4.73 |
| 2025-10-29 | -4.80 |
| 2025-10-28 | -4.88 |
| 2025-10-27 | -5.35 |
| 2025-10-24 | -5.19 |
| 2025-10-23 | -4.73 |
| 2025-10-22 | -4.80 |
| 2025-10-21 | -4.88 |
| 2025-10-20 | -4.96 |
| 2025-10-17 | -5.19 |
| 2025-10-16 | -4.73 |
| 2025-10-15 | -4.80 |
| 2025-10-14 | -4.88 |
| 2025-10-13 | -4.96 |
| 2025-10-10 | -5.19 |
| 2025-10-09 | -4.73 |
| 2025-10-08 | -4.80 |
| 2025-10-07 | -5.08 |
| 2025-10-06 | -5.16 |
| 2025-10-03 | -5.39 |
| 2025-10-02 | -4.92 |
| 2025-10-01 | -5.00 |
| 2025-09-30 | -5.08 |
| 2025-09-29 | -4.92 |
| 2025-09-26 | -5.90 |
| 2025-09-25 | -4.92 |
| 2025-09-24 | -5.59 |
| 2025-09-23 | -5.86 |
| 2025-09-22 | -5.94 |
| 2025-09-19 | -4.41 |
| 2025-09-18 | -3.71 |
| 2025-09-17 | -3.71 |
| 2025-09-16 | -4.30 |
| 2025-09-15 | -4.37 |
| 2025-09-12 | -4.61 |
| 2025-09-11 | -4.14 |
| 2025-09-10 | -4.65 |
| 2025-09-09 | -4.41 |
| 2025-09-08 | -4.76 |